Deletion of ULS1 confers damage tolerance in sgs1 mutants through a Top3-dependent D-loop mediated fork restart pathway.


Journal

DNA repair
ISSN: 1568-7856
Titre abrégé: DNA Repair (Amst)
Pays: Netherlands
ID NLM: 101139138

Informations de publication

Date de publication:
06 2019
Historique:
received: 22 03 2019
accepted: 12 04 2019
pubmed: 22 4 2019
medline: 9 1 2020
entrez: 22 4 2019
Statut: ppublish

Résumé

Homologous recombination (HR)-based repair during DNA replication can apparently utilize several partially overlapping repair pathways in response to any given lesion. A key player in HR repair is the Sgs1-Top3-Rmi1 (STR) complex, which is critical for resolving X-shaped recombination intermediates formed following bypass of methyl methanesulfonate (MMS)-induced damage. STR mutants are also sensitive to the ribonucleotide reductase inhibitor, hydroxyurea (HU), but unlike MMS treatment, HU treatment is not accompanied by X-structure accumulation, and it is thus unclear how STR functions in this context. Here we provide evidence that HU-induced fork stalling enlists Top3 prior to recombination intermediate formation. The resistance of sgs1Δ mutants to HU is enhanced by the absence of the putative SUMO (Small Ubiquitin MOdifier)-targeted ubiquitin ligase, Uls1, and we demonstrate that Top3 is required for this enhanced resistance and for coordinated breaks and subsequent d-loop formation at forks stalled at the ribosomal DNA (rDNA) replication fork block (RFB). We also find that HU resistance depends on the catalytic activity of the E3 SUMO ligase, Mms21, and includes a rapid Rad51-dependent restart mechanism that is different from the slow Rad51-independent HR fork restart mechanism operative in sgs1Δ ULS1+ mutants. These data support a model in which repair of HU-induced damage in sgs1Δ mutants involves an error-prone break-induced replication pathway but, in the absence of Uls1, shifts to one that is higher-fidelity and involves the formation of Rad51-dependent d-loops.

Identifiants

pubmed: 31005681
pii: S1568-7864(19)30094-1
doi: 10.1016/j.dnarep.2019.04.005
pii:
doi:

Substances chimiques

Saccharomyces cerevisiae Proteins 0
TOP3 protein, S cerevisiae 0
SGS1 protein, S cerevisiae EC 3.6.1.-
ULS1 protein, S cerevisiae EC 3.6.1.-
DNA Helicases EC 3.6.4.-
RecQ Helicases EC 3.6.4.12

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

102-113

Subventions

Organisme : NIA NIH HHS
ID : R01 AG021521
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG031862
Pays : United States
Organisme : NCI NIH HHS
ID : F31 CA189800
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

M Rebecca Glineburg (MR)

Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania, 19104, United States; Cell and Molecular Biology Group, Biomedical Graduate Studies, Philadelphia, Pennsylvania, 19104, United States.

Eleanor Johns (E)

Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania, 19104, United States.

F Brad Johnson (FB)

Department of Pathology and Laboratory Medicine, Philadelphia, Pennsylvania, 19104, United States; Cell and Molecular Biology Group, Biomedical Graduate Studies, Philadelphia, Pennsylvania, 19104, United States; The Institute of Aging, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, 19104, United States. Electronic address: johnsonb@pennmedicine.upenn.edu.

Articles similaires

Adenosine Triphosphate Adenosine Diphosphate Mitochondrial ADP, ATP Translocases Binding Sites Mitochondria
Saccharomyces cerevisiae Aldehydes Biotransformation Flavoring Agents Lipoxygenase
1.00
Saccharomyces cerevisiae Lysine Cell Nucleolus RNA, Ribosomal Saccharomyces cerevisiae Proteins
Metabolic Networks and Pathways Saccharomyces cerevisiae Computational Biology Synthetic Biology Computer Simulation

Classifications MeSH